1
0
0
(1 - 17 von 18
)
European Leukemia Network: Contact Information
www.eutos.org
Susanne Saussele III. Medizinische Universitätsklinik Mannheim, Germany Fabrizio Pane Biotecnologie Avanzate and Dipartimento di ...
heiBIB: Saußele, Susanne
katalog.ub.uni-heidelberg.de
124(2014), 21; Defining therapy goals for major molecular remission in chronic myeloid leukemia : results of the randomized CML-study IV / Susanne Saussele, ...
OPUS Würzburg | Distinct characteristics of e13a2 versus e14a2...
opus.bibliothek.uni-wuerzburg.de
The vast majority of chronic myeloid leukemia patients express a BCR-ABL1 fusion gene mRNA encoding a 210 kDa tyrosine kinase which promotes leukemic...
books.google.com › booksManagement of Hematological Cancer in Older People
books.google.lv
Andreas Hochhaus and Susanne Saussele Abstract The impact of age as a poor prognostic factor in chronic myeloid leukemia (CML) has been well described.
SCHATTENBLICK - ONKOLOGIE/1550: Forschung - Ansprechen resistenter...
www.schattenblick.de
Mridul Agrawal, Benjamin Hanfstein, Philipp Erben, Dominik Wolf, Thomas Ernst, Alice Fabarius, Susanne Saussele, Das Purkayastha, Richard C. Woodman, Wolf-Karsten Hofmann, Rüdiger Hehlmann, Andreas Hochhaus, and Martin C. Müller Leukemia advance online publication, 28 January 2014;
Younger patients with chronic myeloid leukemia do well in spite of...
www.scienceopen.com
Authors: Lida Kalmanti, Susanne Saussele, Michael Lauseker, Ulrike Proetel, Martin C. Müller, Benjamin Hanfstein, Annette Schreiber, Alice ...
Clinical Lymphoma Myeloma and Leukemia | Vol 18, Issue 4, Pages...
www.sciencedirect.com
Free Remission in a EURO-SKI Subtrial. Open access - Original research article:
Pages Sébastien Rinaldetti, Markus Pfirrmann, Kirsi Manz, Joelle
Guilhot, ... Susanne Saussele. Download PDF. Article preview ...
Dr Susanne Saussele Defines When Patients With CML Should Change...
www.ajmc.com
Although guidelines from the National Comprehensive Cancer Network and recommendations from the European LeukemiaNet do not identify a failure time point for...
Definitions, methodological and statistical issues for phase 3...
cmlsupport.org.uk
Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet Joelle...
La rete europea LeukemiaNet agevola la ricerca sul cancro -
www.liquidarea.com
Notizie scientifiche in tempo reale
Non-Hodgkin Lymphoma Elevated in Imatinib-Treated CML Survivors
www.cancernetwork.com
A study found an increased incidence of non-Hodgkin lymphoma, but no other secondary malignancies, in chronic myeloid leukemia patients treated with imatinib.
European Stop Tyrosine Kinase Inhibitor Study - Full Text View -...
www.clinicaltrials.gov
European LeukemiaNet. Investigators. Principal Investigator: Susanne Saussele, Dr. Universitätsmedizin Mannheim, Universität Heidelberg ...
Younger patients with chronic myeloid leukemia do well in spite of...
schlr.cnki.net
Lida Kalmanti,Susanne Saussele,Michael Lauseker,Ulrike Proetel,Martin C. Müller,Benjamin Hanfstein,Annette Schreiber,Alice Fabarius,Markus Pfirrmann ...
Using … Cancer Drug Could Save Many Millions of Dollars
New research suggests little risk, huge financial upside of putting patients with chronic myeloid leukemia on … form of Gleevec
Long-term outcome of patients with newly diagnosed chronic myeloid...
is.muni.cz
... Guntram BÜSCHE, Claudia HAFERLACH, Susanne SCHNITTGER, Martin C MÜLLER, Andreas REITER, Ute BERGER, Susanne SAUSSELE, Andreas HOCHHAUS and Rüdiger HEHLMANN. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia - A randomized comparison of ...
Alle Infos zum Namen "Susanne Saussele"
sortiert nach Relevanz / Datum